Search | IOVS | ARVO Journals

Showing 1 – 20 of 39

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Outcomes of AVF treatment switch in DME patients in US clinical practice: Analysis of the AAO IRIS Database

Vanessa Shih; Flora Lum; Nancy Holekamp; Szilard Kiss; Bhavya Burugapalli; Joanna Campbell; Charles Clifton Wykoff

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3865. doi:

ARVO Annual Meeting Abstract July 2019

Ocular syphilis: clinical manifestations and visual outcomes

Merav Koschitzky; Kunyong Xu; Szilard Kiss

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):857. doi:

ARVO Annual Meeting Abstract July 2018

Ultra-wide-field autofluorescence imaging of retinal detachment compared to retinoschisis

Jennifer Beth Nadelmann; Mrinali Patel Gupta; Szilard Kiss; Donald J D'Amico; Anton Orlin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4234. doi:

ARVO Annual Meeting Abstract June 2017

Persistent diabetic macular edema after 6 months of anti-VEGF therapy is associated with diminished long-term improvement in vision: a post-hoc analysis of Protocol I

Scott M Whitcup; Joanna Campbell; Anat Loewenstein; Pravin U Dugel; Nancy Holekamp; Szilard Kiss; Albert J Augustin; Vanessa Shih; Jeff Lai; Charles Clifton Wykoff; Srinivas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1906. doi:

ARVO Annual Meeting Abstract June 2017

Trends in diabetic vitrectomy at single academic institution

Neepa Shah; Jennifer Oluyemisi Adeghate; Mrinali P. Gupta; Anton Orlin; Donald J D'Amico; Szilard Kiss

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2816. doi:

ARVO Annual Meeting Abstract June 2017

Non-Mydriatic Retina Evaluation with Macular OCT and Ultra-Widefield Fundus Photography in Pregnant or Nursing Patients.

Alexander Port; Ranjodh Singh; Daniel Kornberg; Anton Orlin; Donald J D'Amico; Mrinali P. Gupta; Szilard Kiss

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1862. doi:

ARVO Annual Meeting Abstract September 2016

Real-world treatment patterns in injection cost and frequency for ranibizumab versus aflibercept in patients with wet age-related macular degeneration: A 2-year US claims analysis

Szilard Kiss; Yamina Rajput; Carlos Quezada Ruiz; Kathleen Wilson; Alice Huang; David M Smith; Helen Varker; Stephen S Johnston

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3335. doi:

ARVO Annual Meeting Abstract September 2016

Reversal of peripheral ischemia following Anti-VEGF treatment for diabetic retinopathy

Ariana Levin; Irene Rusu; Anton Orlin; Mrinali Gupta; Donald J D'Amico; Szilard Kiss

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Consistency of visual acuity response to anti-VEGF therapy in diabetic macular edema patients: An analysis of DRCRnet Protocol I data

Scott M Whitcup; Joanna Campbell; Nancy Holekamp; Szilard Kiss; Anat Loewenstein; Albert J Augustin; Allen C Ho; Victor Gonzalez; Vanessa Shih; Amelia Orejudos; Pravin U Dugel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract June 2015

Ultra-Widefield Imaging of Vitreoretinal Pathology in the Setting of the Boston Keratoprosthesis

Daniel L Kornberg; Nicolas A Yannuzzi; Michael A Klufas; Donald J D'Amico; Szilard Kiss

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3082. doi:

ARVO Annual Meeting Abstract June 2015

Dissecting the Intravitreal Injection: The Role of Silicones

Jesse T McCann; Yale Fisher; Szilard Kiss; Samuel Nemiroff

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4174. doi:

ARVO Annual Meeting Abstract June 2015

Long term complications of pars plana vitrectomy and the effect on intraocular pressure and the optic nerve

Irene M Rusu; Kelley J Bohm; John T Pena; Robison Vernon Paul Chan; Szilard Kiss; Donald J D'Amico; Anton Orlin

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5102. doi:

ARVO Annual Meeting Abstract June 2015

Association of Geographic Atrophy (GA) and Visual Acuity (VA) with anti-VEGF Therapy Exposure in the Comparison of Age-related Macular Degeneration Treatments Trial (CATT)

Szilard Kiss; Samuel B. Barone; Steven Butler; Sherri Van Everen; Melvin Rabena; Roman Rubio; Thomas Walter Chalberg

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2837. doi:

ARVO Annual Meeting Abstract June 2015

Comorbidity and Healthcare Visit Burden in Elderly Diabetic Macular Edema Patients

Joanna Campbell; Pravin U Dugel; Ashley Cole; Orsolya Lunacsek; Amanda Forys; Herman Chen; Hitesh Chandwani; Szilard Kiss

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2145. doi:

ARVO Annual Meeting Abstract June 2015

Comorbidity and healthcare visit burden in working-age commercially insured diabetic macular edema patients

Hitesh Chandwani; Szilard Kiss; Ashley Cole; Vaishali D Patel; Orsolya Lunacsek; Pravin U Dugel

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2146. doi:

ARVO Annual Meeting Abstract April 2014

Treatment Patterns and Associated Costs of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration

Szilard Kiss; Pravin U Dugel; Kathleen Wilson; Alice Huang; David Smith; Helen Varker; Stephen S Johnston; Adam Turpcu

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5596. doi:

ARVO Annual Meeting Abstract April 2014

Increased health care utilization among patients with diabetic macular edema compared with diabetic patients without edema

Chris John Wallick; Ryan N Hansen; Joanna Campbell; Jonathan W Kowalski; Szilard Kiss; Sean D Sullivan

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1751. doi:

ARVO Annual Meeting Abstract April 2014

Feasibility and Clinical Utility of Ultra-Widefield Indocyanine Green Angiography

Michael Klufas; Nicolas A Yannuzzi; Claudine E Pang; Sowmya Srinivas; Srinivas R Sadda; K Bailey Freund; Szilard Kiss

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):208. doi:

ARVO Annual Meeting Abstract April 2014

Real-World Vision Outcomes in RVO Treated With Anti-VEGF Injections- An Analysis of EMR Data From a Large Health System

Hitesh Chandwani; Ashley L Cole; Joanna Campbell; Herbert Ingraham; Arghavan Almony; Szilard Kiss; Steven Marks; Jonathan W Kowalski; Nancy M Holekamp

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3919. doi:

ARVO Annual Meeting Abstract April 2014

Extent of Retinopathy and Treatment of Diabetic Patients Referred for Ophthalmic Evaluation: 8 Year Experience at a Tertiary Referral Center

Thomas L Berenberg; Anton Orlin; Donald J D'Amico; Szilard Kiss

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2283. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Outcomes of AVF treatment switch in DME patients in US clinical practice: Analysis of the AAO IRIS Database

Ocular syphilis: clinical manifestations and visual outcomes

Ultra-wide-field autofluorescence imaging of retinal detachment compared to retinoschisis

Persistent diabetic macular edema after 6 months of anti-VEGF therapy is associated with diminished long-term improvement in vision: a post-hoc analysis of Protocol I

Trends in diabetic vitrectomy at single academic institution

Non-Mydriatic Retina Evaluation with Macular OCT and Ultra-Widefield Fundus Photography in Pregnant or Nursing Patients.

Real-world treatment patterns in injection cost and frequency for ranibizumab versus aflibercept in patients with wet age-related macular degeneration: A 2-year US claims analysis

Reversal of peripheral ischemia following Anti-VEGF treatment for diabetic retinopathy

Consistency of visual acuity response to anti-VEGF therapy in diabetic macular edema patients: An analysis of DRCRnet Protocol I data

Ultra-Widefield Imaging of Vitreoretinal Pathology in the Setting of the Boston Keratoprosthesis

Dissecting the Intravitreal Injection: The Role of Silicones

Long term complications of pars plana vitrectomy and the effect on intraocular pressure and the optic nerve

Association of Geographic Atrophy (GA) and Visual Acuity (VA) with anti-VEGF Therapy Exposure in the Comparison of Age-related Macular Degeneration Treatments Trial (CATT)

Comorbidity and Healthcare Visit Burden in Elderly Diabetic Macular Edema Patients

Comorbidity and healthcare visit burden in working-age commercially insured diabetic macular edema patients

Treatment Patterns and Associated Costs of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration

Increased health care utilization among patients with diabetic macular edema compared with diabetic patients without edema

Feasibility and Clinical Utility of Ultra-Widefield Indocyanine Green Angiography

Real-World Vision Outcomes in RVO Treated With Anti-VEGF Injections- An Analysis of EMR Data From a Large Health System

Extent of Retinopathy and Treatment of Diabetic Patients Referred for Ophthalmic Evaluation: 8 Year Experience at a Tertiary Referral Center

To View More...

You must be signed into an individual account to use this feature.